Erythrocyte-mediated drug delivery for the prevention of restenosis after coronary artery stent implantation:TROY-study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Dexamethasone (Primary)
- Indications Restenosis
- Focus Therapeutic Use
- Acronyms TROY
- 04 Aug 2007 New trial record.
- 12 Jun 2007 Biomarkers information updated